Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/09/2017 08/10/2017 08/11/2017 08/14/2017 08/15/2017 Date
26.57(c) 26.26(c) 26.41(c) 26.68(c) 26.47(c) Last
3 405 143 5 854 333 3 285 998 3 835 639 5 490 216 Volume
+0.23% -1.17% +0.57% +1.02% -0.79% Change
More quotes
Financials ($)
Sales 2017 8 954 M
EBIT 2017 2 167 M
Net income 2017 1 241 M
Debt 2017 4 773 M
Yield 2017 -
Sales 2018 9 589 M
EBIT 2018 2 415 M
Net income 2018 1 536 M
Debt 2018 3 379 M
Yield 2018 -
P/E ratio 2017 33,05
P/E ratio 2018 25,19
EV / Sales2017 4,59x
EV / Sales2018 4,14x
Capitalization 36 320 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.Its products and technologies are used to diagnose or treat medical conditions, including heart, digestive, pulmonary, vascular, urological, women's... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
08/10 BOSTON SCIENTIFIC : Patent Issued for Wireless Recharging System and Method for ..
08/10 BOSTON SCIENTIFIC : Reports Summarize Diabetes Findings from National Institute ..
08/10 EARNINGS REVIEW AND FREE RESEARCH RE : Boston Scientific’s Q2 Top-line Gre..
08/07 BOSTON SCIENTIFIC CORPORATION (NYSE : BSX) Files An 8-K Entry into a Material De..
08/07 BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Termination..
08/05 INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – SVP Sold 12,433 shares of St..
08/05 INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – SVP Sold 7,900 shares of Sto..
08/04 BOSTON SCIENTIFIC : Judicial Panel on Multidistrict Litigation Issues Order on B..
08/03 BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
08/03 INSIDER TRADING ACTIVITY BOSTON SCIE : BSX) – EVP Sold 10,000 shares of St..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/03DJHot Stocks to Watch in the U.S. and Canada
08/01DJAthenahealth Makes a Shareholder-Backed Shake-Up, Keeping CEO
07/24 Autos, airlines hit in sluggish start to European trading week
07/24 ROYAL PHILIPS : Philips targets order book growth of 4-6 percent in 2017 - CEO
07/24DJROYAL PHILIPS : 2Q Net Profit Rises; Begins EUR1.5 Billion Share Buyback Program
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
Latest Tweets
11:58aBoston Scientific Corporation $BSX Stake Boosted by Global X Management Co. L..
1
08:17aNeovasc downgraded by Zacks Investment Research to sell.  
08/15Wetherby Asset Management Inc. Acquires 523 Shares of Boston Scientific Corpo..
1
08/15Global Electrophysiology Catheters Market to Grow at a CAGR of 9.2% by 2021: ..
1
08/15Global Electrophysiology Catheters Market to Grow at a CAGR of 9.2% by 2021: ..
1
More tweets
Qtime:92
News from SeekingAlpha
08/09 Boston Scientific Corp (BSX) Presents at Canaccord Genuity Growth Broker Conf..
08/08 Book Profits On Puma Biotechnology - Cramer's Lightning Round (8/7/17)
08/07 Vanguard Brings You Healthy Returns With Less Volatility
08/04 SNIPPET ROUNDUP : Two Approvals, Two Setbacks And A Price War
08/01 You Should Not Miss Edwards Lifesciences And Its TAVR Story In 2017
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 30,9 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian Meredith Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION22.38%36 320
THERMO FISHER SCIENTIFIC INC.23.01%69 232
DANAHER3.49%55 964
INTUITIVE SURGICAL55.38%36 607
ROYAL PHILIPS9.52%35 080
ILLUMINA52.14%28 370